Recent Articles
- Pattern Bioscience Strengthens Leadership Team with Key Appointments
- Pattern Bioscience Selected as Winner of ADLM Disruptive Technology Award
- Pattern Bioscience Secures $28.7 Million in Series C Financing
- Pattern Bioscience Appoints Carey-Ann Burnham as Chief Clinical Officer
- Pattern Receives FDA “Breakthrough Device Designation” for Pneumonia Action Panel